4.8 Article

Cannabinoid Receptor 2 Counteracts Interleukin-17-Induced Immune and Fibrogenic Responses in Mouse Liver

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice

Xiaoni Kong et al.

HEPATOLOGY (2012)

Editorial Material Immunology

Negative regulators take center stage

Silvia Monticelli et al.

NATURE IMMUNOLOGY (2012)

Review Pharmacology & Pharmacy

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

A. Mallat et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Article Medicine, Research & Experimental

Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation

Guoliang Cui et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Editorial Material Gastroenterology & Hepatology

The liver X receptor in hepatic stellate cells: A novel antifibrogenic target?

Ariane Mallat et al.

JOURNAL OF HEPATOLOGY (2011)

Review Immunology

Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27

Caroline Pot et al.

SEMINARS IN IMMUNOLOGY (2011)

Review Immunology

Th17 cells and their associated cytokines in liver diseases

Fouad Lafdil et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2010)

Article Gastroenterology & Hepatology

Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration

Fatima Teixeira-Clerc et al.

HEPATOLOGY (2010)

Article Immunology

Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent

Mark S. Wilson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Immunology

γδ T cells protect against lung fibrosis via IL-22

Philip L. Simonian et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Multidisciplinary Sciences

Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor

Muhammad Shamsul Alam et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Gastroenterology & Hepatology

Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice

Jeon-Ok Moon et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)

Article Gastroenterology & Hepatology

The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease

Arnaud Lemmers et al.

HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

Immune Interactions in Hepatic Fibrosis

Andrew P. Holt et al.

CLINICS IN LIVER DISEASE (2008)

Review Gastroenterology & Hepatology

Mechanisms of hepatic fibrogenesis

Scott L. Friedman

GASTROENTEROLOGY (2008)

Article Multidisciplinary Sciences

Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

Huafeng Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Cardiac & Cardiovascular Systems

IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation

Dolores M. Cortez et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

Sandor Batkai et al.

FASEB JOURNAL (2007)

Review Pharmacology & Pharmacy

Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases

Ariane Mallat et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Article Gastroenterology & Hepatology

Interleukin-15 increases hepatic regenerative activity

Ayako Suzuki et al.

JOURNAL OF HEPATOLOGY (2006)

Article Biochemistry & Molecular Biology

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Fatima Teixeira-Clerc et al.

NATURE MEDICINE (2006)

Review Immunology

Cannabinoid-based drugs as anti-inflammatory therapeutics

TW Klein

NATURE REVIEWS IMMUNOLOGY (2005)

Article Gastroenterology & Hepatology

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

B Julien et al.

GASTROENTEROLOGY (2005)

Review Immunology

Fibrotic disease and the TH1/TH2 paradigm

TA Wynn

NATURE REVIEWS IMMUNOLOGY (2004)